Is an Inhibitor of Histamine-Forming Enzyme a New Type of "Anti-histamine" ?
组胺形成酶抑制剂是新型“抗组胺药”吗?
基本信息
- 批准号:61870012
- 负责人:
- 金额:$ 13.44万
- 依托单位:
- 依托单位国家:日本
- 项目类别:Grant-in-Aid for Developmental Scientific Research
- 财政年份:1986
- 资助国家:日本
- 起止时间:1986 至 1988
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
a-Fluoromethylhistidine (FMH) is a specific inhibitor of L-histidine decarboxylase (HDC), a histamine-forming enzyme. The purpose of this study is as follows (1) Is histamine depletion caused by administration of FMH effective as drugs for pathological conditions for which histamine is responsible? (2) Does the histamine depletion evoke serious side effects, beacause histamine plays roles in various physiological states? In terms of (1), FMH strogly inhibited the histamine production in gastric carcinoid of Mastomys natalensis and completely protected peptic ulcer formation caused by excess acid production. Also FMH inhibited a pica reaction, a kaolin intake response after double rotation stimutation in rats, which is a model of motion sickness. In terms of (2), histamine depletion caused by long-term administration of FMH in guinea-pigs did not change the sensitivity of histamine H_1 and H_2 receptors, as judged by the insignificant changes in [3H]-mepyramine binding and cAMP producti … More on as chemical markers, and contractions of the ileum and atrium as physiological responses, respectively. in screening test of general pharmacology of FMN in mice and rats, no significan effects were observed except in higher doses (greater than 100 mg/kg). On closer examination of its effect on CNS, however, FMH affected a little in the circadian rhythms of plasma concentrations of corticosteron and ACTH or sleep-awakeness, and retarded the phase of free-run rhythms of spontaneous and drinking behaviors. FMH also did not affect the regulation of immune responses like antibody formation and contact sensitivity reaction in the skin caused by dinitrophenylfluorobenzene in guinea-pigs. The pharmacokinetical analysis showed that FMH administered i.v. was not easily transported into the brain, stomach and liver, but rapildy rapidly excreted from the kidney, giving the basis for future studies. To sum up, the possiblity was demonstrated that FMH might be useful as a drug f or pep-tic ulcer or motion sickness and histamine depletion did not cause serious side effects, although further studies will be required. Less
A-氟甲基组织(FMH)是一种特异性抑制剂,是一种组胺形成酶的L-抗二烷型脱羧酶(HDC)。这项研究的目的如下(1)是组胺耗竭是由施用的FMH施用作为病理疾病的药物的施用引起的? (2)组胺耗竭会引起严重的副作用,比起组胺在各种物理状态下起作用吗?就(1)而言,FMH串扰抑制了乳腺豆菌的胃癌的组胺产生,并完全保护了由过量酸产生引起的消化性溃疡形成。 FMH还抑制了PICA反应,这是大鼠双旋转刺激后的高岭土摄入反应,这是运动疾病的模型。在(2)方面,豚鼠中FMH长期给药引起的组胺耗竭并没有改变组胺H_1和H_2受体的敏感性,这是由[3H] - 雌激素 - 米皮胺结合的无关紧要的变化和cAMP Products and Camp Products的微不足道的变化所判断的……在化学标志物,化学标志物和乳房中的质量更大。在小鼠和大鼠FMN一般药理学的筛查测试中,除了较高剂量(大于100 mg/kg)外,没有观察到显着影响。然而,在仔细研究其对中枢神经系统的影响时,FMH在血浆浓度的皮质蛋白酶和ACTH或ACTH或睡眠的昼夜节律上有所影响,并阻碍了赞助和饮酒行为的自由节奏的阶段。 FMH也不影响豚鼠二硝基氟氟苯引起的皮肤中的抗体形成和接触敏感反应等免疫反应的调节。药代动力学分析表明,FMH给药了。不容易将其转移到大脑,摊位和肝脏中,但是肾脏迅速超过了肾脏,为将来的研究提供了基础。总而言之,可能性证明,FMH可能是一种药物FMH或疾病,组胺耗竭并没有引起严重的副作用,尽管需要进一步的研究,但需要进一步研究。较少的
项目成果
期刊论文数量(86)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Masahiro,Morita: "Pica as an index of motion sickness of rats." Otorhinolaryngology. 50. 188-192 (1988)
Masahiro,Morita:“异食癖是老鼠晕动病的指标。”
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Takehiko,Watanabe: Handbook of Experimental Pharmacology; Histamine and Histamine Antagonists.Springer, 20 (1989)
Takehiko,Watanabe:实验药理学手册;
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
渡邊建彦: "蕁麻疹,皮膚科MOOK12" 金原出版, 190-201 (1988)
渡边武彦:“荨麻疹,皮肤病学 MOOK12” Kanehara Publishing,190-201(1988)
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Noriaki,TAkeda: Bical Sciences in Space 1986. MYU Research, 173-177 (1987)
Noriaki,TAkeda:太空生物科学 1986。MYU Research,173-177(1987)
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
MAEYAMA Kazutaka其他文献
MAEYAMA Kazutaka的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('MAEYAMA Kazutaka', 18)}}的其他基金
Real-time monitoring of histamine released from a single histamine neuron with a histamine microsensor using recombinant histamine oxidase
使用重组组胺氧化酶的组胺微传感器实时监测单个组胺神经元释放的组胺
- 批准号:
13557008 - 财政年份:2001
- 资助金额:
$ 13.44万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
NEW DEVELOPMENT OF PHARMACOLOGICAL RESEARCH FOR HISTAMINE : USING MAST CELL DEFICIENT RAT
组胺药理学研究的新进展:利用肥大细胞缺陷大鼠
- 批准号:
07557011 - 财政年份:1995
- 资助金额:
$ 13.44万 - 项目类别:
Grant-in-Aid for Scientific Research (A)
REGULATORY MECHANISM OF HISTAMINE RELEASE BY CA LCIUM : USING RAT BASOPHILIC LEUKEMIA CELL LINE
钙释放组胺的调节机制:使用大鼠嗜碱性白血病细胞系
- 批准号:
05670081 - 财政年份:1993
- 资助金额:
$ 13.44万 - 项目类别:
Grant-in-Aid for General Scientific Research (C)
REGULATION OF HISTAMINE RELEASE AND SYNTHESIS; USING BASOPHILIC LEUKEMIA CELL LINES
组胺释放和合成的调节;
- 批准号:
03670088 - 财政年份:1991
- 资助金额:
$ 13.44万 - 项目类别:
Grant-in-Aid for General Scientific Research (C)
相似国自然基金
表达组氨酸脱羧酶的髓系来源抑制细胞促进肠道菌群失调小鼠发生乳腺癌的机制研究
- 批准号:81860490
- 批准年份:2018
- 资助金额:34.8 万元
- 项目类别:地区科学基金项目
损伤性高迁移率族蛋白家族协同髓系细胞来源Wnt信号通路在肝再生中的作用机制研究
- 批准号:81770624
- 批准年份:2017
- 资助金额:57.0 万元
- 项目类别:面上项目
发酵肉制品中组胺的来源和形成机制的研究
- 批准号:31301552
- 批准年份:2013
- 资助金额:23.0 万元
- 项目类别:青年科学基金项目
组胺对NMDA诱发的兴奋性神经元毒性的保护作用及其机制
- 批准号:30572176
- 批准年份:2005
- 资助金额:27.0 万元
- 项目类别:面上项目
相似海外基金
The Role of Hypothalamic H3 Histamine Receptors in Regulation of Striatal Function
下丘脑 H3 组胺受体在纹状体功能调节中的作用
- 批准号:
10534998 - 财政年份:2022
- 资助金额:
$ 13.44万 - 项目类别:
The Role of Hypothalamic H3 Histamine Receptors in Regulation of Striatal Function
下丘脑 H3 组胺受体在纹状体功能调节中的作用
- 批准号:
10685282 - 财政年份:2022
- 资助金额:
$ 13.44万 - 项目类别:
Dysregulation of dopamine receptors in the basal ganglia in OCD and tic disorders: Positron Emission Tomography with [11C]-PHNO
强迫症和抽动障碍中基底神经节多巴胺受体的失调:[11C]-PHNO 正电子发射断层扫描
- 批准号:
10672999 - 财政年份:2022
- 资助金额:
$ 13.44万 - 项目类别:
Dysregulation of dopamine receptors in the basal ganglia in OCD and tic disorders: Positron Emission Tomography with [11C]-PHNO
强迫症和抽动障碍中基底神经节多巴胺受体的失调:[11C]-PHNO 正电子发射断层扫描
- 批准号:
10501537 - 财政年份:2022
- 资助金额:
$ 13.44万 - 项目类别: